 |
|
Agoraphobia and Follicle-Stimulating Hormone Levels between Tamoxifen and Goserelin versus Tamoxifen Alone in Premenopausal Hormone Receptor-Positive Breast Cancer: A 12-Month Prospective Randomized Study
Jung-Yoon Heo, Hawoo Yi, Maurizio Fava, David Mischoulon, Kiwon Kim, Sechang Yoon, Hong Jin Jeon, Jeong Eon Lee
Psychiatry Investig. 2017;14(4):491-498. Published online 2017 Jul 11 DOI: https://doi.org/10.4306/pi.2017.14.4.491
|
|
Ovarian suppression for adjuvant treatment of hormone receptor-positive early breast cancer
Kim Tam Bui, Melina L Willson, Shom Goel, Jane Beith, Annabel Goodwin
Cochrane Database of Systematic Reviews.2020;[Epub] CrossRef Chemotherapeutic agents for the treatment of metastatic breast cancer: An update
Mariam Abotaleb, Peter Kubatka, Martin Caprnda, Elizabeth Varghese, Barbora Zolakova, Pavol Zubor, Radka Opatrilova, Peter Kruzliak, Patrik Stefanicka, Dietrich Büsselberg
Biomedicine & Pharmacotherapy.2018; 101: 458. CrossRef
|